Droia Ventures is a venture capital fund based in Luxembourg. It invests in companies developing treatments for cancer and genetic diseases, focusing on Series A and B funding stages. The fund has backed firms like Vico Therapeutics and is committed to advancing biotech and pharma by supporting early and mid-stage companies.